Lisanti Capital Growth LLC purchased a new stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 62,415 shares of the company’s stock, valued at approximately $3,158,000. Several other large investors also recently […]
Midwest Professional Planners LTD Increases Position in Ionis Pharmaceuticals, Inc (NASDAQ:IONS) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) had its target price hoisted by Piper Sandler from $60.00 to $62.00 in a research note issued on Thursday, Benzinga reports. The firm currently has an “overweight” rating on the stock. Piper Sandler’s target price points to a potential upside of 21.62% from the company’s current price. Several […]
Ionis Pharmaceuticals, Inc (NASDAQ:IONS) EVP Sells $428,000 00 in Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Simplicity Solutions LLC lowered its stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 2.1% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 12,198 shares of the company’s stock after selling 267 shares during the period. Simplicity Solutions LLC’s holdings in Ionis […]